Citadel Advisors »

Springworks Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $18M 491k 36.50
2023-09-30 $664k 29k 23.12
2023-06-30 $687k 26k 26.22
2023-03-31 $1.1M 43k 25.74
2022-12-31 $4.6M 178k 26.01
2022-06-30 $4.9M 200k 24.62
2022-03-31 $5.6M 100k 56.44
2021-12-31 $3.4M 54k 61.98
2021-09-30 $11M 172k 63.44
2021-06-30 $67M 812k 82.45
2021-03-31 $59M 801k 73.57
2020-12-31 $58M 793k 72.52
2020-09-30 $36M 759k 47.67
2020-06-30 $39M 925k 42.00
2020-03-31 $26M 943k 27.00
2019-12-31 $36M 931k 38.49
2019-09-30 $29M 1.3M 21.68